Integra Lifesciences Holdings Corp (NAS:IART)
$ 24.8 -0.64 (-2.51%) Market Cap: 1.91 Bil Enterprise Value: 3.68 Bil PE Ratio: 0 PB Ratio: 1.26 GF Score: 71/100

Q4 2022 Integra Lifesciences Holdings Corp Earnings Call Transcript

Feb 22, 2023 / 01:30PM GMT
Release Date Price: $56.05 (-1.16%)
Operator

Thank you for standing by, and welcome to Integra LifeSciences Fourth Quarter and Full Year 2022 Financial Results Call. (Operator Instructions)

I would now like to hand the call over to Chris Ward, Senior Director, Investor Relations. Please go ahead.

Chris Ward

Thank you, Lateef. Good morning, and thank you for joining the Integra LifeSciences Fourth Quarter and Full Year 2022 Earnings Conference Call. Joining me on the call this morning are Jan De Witte, President and Chief Executive Officer; Jeff Mosebrook, Chief Accounting Officer; and Mathieu Aussermeier, Vice President, Corporate FP&A, Investor Relations and Treasurer.

Earlier today, we issued a press release announcing our fourth quarter 2022 and full year 2022 financial results. The release and corresponding earnings presentation, which we will feature during the call, are available at integralife.com under Investors, Events and Presentations in a file named Fourth Quarter 2022 Earnings Call Presentation.

Before we begin, I would like to remind you that many of the statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot